DENTSPLY SIRONA Q3 EPS Estimate Lowered by William Blair

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Equities researchers at William Blair reduced their Q3 2025 EPS estimates for DENTSPLY SIRONA in a research report issued on Thursday, May 8th. William Blair analyst B. Vazquez now expects that the medical instruments supplier will post earnings of $0.49 per share for the quarter, down from their prior forecast of $0.51. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. William Blair also issued estimates for DENTSPLY SIRONA’s Q3 2026 earnings at $0.53 EPS.

Other equities research analysts also recently issued research reports about the stock. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 target price for the company. in a research note on Tuesday, April 15th. Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Barrington Research upped their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the company an “outperform” rating in a research note on Monday. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Finally, Piper Sandler lowered their target price on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating for the company in a research note on Wednesday, April 30th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $20.36.

DENTSPLY SIRONA Stock Up 5.9%

Shares of NASDAQ:XRAY opened at $16.75 on Monday. DENTSPLY SIRONA has a 52 week low of $12.16 and a 52 week high of $28.69. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The company has a market capitalization of $3.34 billion, a PE ratio of -8.09, a PEG ratio of 1.80 and a beta of 0.92. The company has a 50 day moving average price of $14.37 and a two-hundred day moving average price of $17.49.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $879.00 million during the quarter, compared to the consensus estimate of $854.75 million. During the same period in the previous year, the firm posted $0.42 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 7.8% compared to the same quarter last year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. QVIDTVM Management LLC boosted its holdings in DENTSPLY SIRONA by 1.1% during the first quarter. QVIDTVM Management LLC now owns 463,866 shares of the medical instruments supplier’s stock worth $6,930,000 after purchasing an additional 5,000 shares during the last quarter. Nuveen LLC acquired a new stake in DENTSPLY SIRONA in the first quarter valued at $6,299,000. Aigen Investment Management LP acquired a new stake in DENTSPLY SIRONA in the first quarter valued at $177,000. Entropy Technologies LP lifted its stake in DENTSPLY SIRONA by 116.7% in the first quarter. Entropy Technologies LP now owns 72,002 shares of the medical instruments supplier’s stock valued at $1,076,000 after acquiring an additional 38,783 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in DENTSPLY SIRONA by 31.2% in the first quarter. Invesco Ltd. now owns 523,317 shares of the medical instruments supplier’s stock valued at $7,818,000 after acquiring an additional 124,327 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction that occurred on Monday, March 3rd. The stock was acquired at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares of the company’s stock, valued at $1,353,341.21. This trade represents a 22.66% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.50% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 3.82%. The ex-dividend date was Friday, March 28th. DENTSPLY SIRONA’s payout ratio is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.